A Plus Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	835.89	769.59	675.05	541.85	503.29
Revenue Growth (YoY)	8.62%	14.01%	24.58%	7.66%	-
Cost of Revenue	262.43	234.81	214.37	195.46	185.36
Gross Profit	573.46	534.78	460.67	346.39	317.93
Selling, General & Admin	318.06	299.15	233.43	237.16	203.12
Research & Development	46.64	53.34	59.54	63.08	79.96
Operating Expenses	364.7	352.32	293.13	299.65	275.4
Operating Income	208.76	182.46	167.54	46.74	42.53
Interest Expense	-2.17	-2.19	-2.69	-2.2	-1.19
Interest & Investment Income	3.79	2.27	1.71	0.42	2.05
Earnings From Equity Investments	3.66	-	-	-	-
Currency Exchange Gain (Loss)	1.6	1.68	0.03	-	-
Other Non Operating Income (Expenses)	0.47	3.35	-163.59	1.1	4.36
EBT Excluding Unusual Items	216.12	187.57	3	46.06	47.75
Gain (Loss) on Sale of Assets	-0	-0.01	-	-	-
Other Unusual Items	0.02	-	0.04	-	-
Pretax Income	216.14	187.56	3.04	46.06	47.75
Income Tax Expense	46.6	36.5	14.34	10.43	8.71
Earnings From Continuing Operations	169.54	151.06	-11.31	35.63	39.04
Minority Interest in Earnings	-0.16	-	-	-2.69	-2.97
Net Income	169.38	151.06	-11.31	32.94	36.06
Net Income to Common	169.38	151.06	-11.31	32.94	36.06
Net Income Growth	12.13%	-	-	-8.66%	-
Shares Outstanding (Basic)	33	30	30	29	29
Shares Outstanding (Diluted)	33	30	30	29	29
Shares Change (YoY)	8.36%	0.37%	4.70%	0.95%	-
EPS (Basic)	5.16	4.99	-0.37	1.15	1.26
EPS (Diluted)	5.15	4.97	-0.37	1.14	1.26
EPS Growth	3.62%	-	-	-9.52%	-
Free Cash Flow	144.79	152.09	149.72	-168.55	107.35
Free Cash Flow Per Share	4.40	5.01	4.95	-5.83	3.75
Dividend Per Share	5.000	4.000	2.700	-	-
Dividend Growth	25.00%	48.15%	-	-	-
Gross Margin	68.60%	69.49%	68.24%	63.93%	63.17%
Operating Margin	24.98%	23.71%	24.82%	8.63%	8.45%
Profit Margin	20.26%	19.63%	-1.68%	6.08%	7.17%
Free Cash Flow Margin	17.32%	19.76%	22.18%	-31.11%	21.33%
EBITDA	224.9	197.32	181.35	68.17	68.01
EBITDA Margin	26.91%	25.64%	26.86%	12.58%	13.51%
D&A For EBITDA	16.14	14.86	13.81	21.43	25.48
EBIT	208.76	182.46	167.54	46.74	42.53
EBIT Margin	24.98%	23.71%	24.82%	8.63%	8.45%
Effective Tax Rate	21.56%	19.46%	472.12%	22.64%	18.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.